Who
Timothy Robert Henrichs
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Neuraxis.
In numbers
- Trades disclosed
- 11
- Buys
- 2
- Sells
- 0
- Bought
- $39K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Jan 2025
- Last trade
- 8 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Oct 2026filed 8 Oct 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Bought | $9,3751,937 at $4.84 | filing |
| 13 Aug 2026filed 17 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $888K141,479 at $6.28 | filing |
| 13 Aug 2026filed 17 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $888K141,479 at $6.28 | filing |
| 1 Apr 2026filed 3 Apr 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Bought | $15K7,593 at $1.96 | filing |
| 1 Apr 2026filed 3 Apr 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Bought | $15K7,593 at $1.96 | filing |
| 22 Jan 2026filed 26 Feb 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $348K75,231 at $4.63 | filing |
| 22 Jan 2026filed 26 Feb 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $348K75,231 at $4.63 | filing |
| 18 Mar 2025filed 10 Sep 2025 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $20K8,037 at $2.43 | filing |
| 18 Mar 2025filed 10 Sep 2025 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $243K100,000 at $2.43 | filing |
| 4 Mar 2025filed 10 Sep 2025 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $144K66,000 at $2.18 | filing |
| 3 Jan 2025filed 10 Sep 2025 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $165K67,980 at $2.42 | filing |
News
Head to Head Contrast: Green Thumb Industries (OTCMKTS:GTBIF) vs. NeurAxis (NASDAQ:NRXS)NRXS · dailypolitical.com · 18 Oct 2026Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NRXS · tickerreport.com · 15 Oct 2026Critical Analysis: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)NRXS · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Timothy Robert Henrichs; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.